A randomized, double-blind, phase (Ph) III study of the irinotecan-based chemotherapy FOLFIRI plus ramucirumab (RAM) or placebo (PL) in patients (pts) with metastatic colorectal carcinoma (mCRC) ...
Centralized Review Offers Promise for the Clinician, the Pathologist, and the Patient With Newly Diagnosed Lymphoma Medulloblastomas are heterogeneous and include relatively good-prognosis tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results